Opthea limited stock
WebDec 9, 2024 · Opthea Limited's (ASX:OPT) top owners are individual investors with 44% stake, while 26% is held by hedge funds Simply Wall St December 9, 2024, 3:00 PM · 4 min read Every investor in Opthea... WebApr 10, 2024 · Nochomovitz covers the Healthcare sector, focusing on stocks such as Opthea Limited Sponsored ADR, Ultragenyx Pharmaceutical, and Apellis Pharmaceuticals. ... J.P. Morgan also upgraded the stock ...
Opthea limited stock
Did you know?
WebMar 23, 2024 · The Opthea Limited Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. WebOpthea Limited - ADR (OPT) Stock Price Today, News, Quotes, FAQs and Fundamentals 10.30% 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. OPT Opthea Limited - ADR 180 Alerts $4.17 $0.00 (0.00%) Today $0.00 0.00 (0.00%) After Hours Market Cap $245.27M Volume (M) 629.00 52-Wk High $8.50 52-Wk Low $4.19 …
WebDec 8, 2024 · This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ... WebApr 12, 2024 · Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company’s …
WebOpthea Limited American Depositary Shares (OPT) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Charts Key Data Bid Price and Ask Price The bid … WebApr 6, 2024 · What is Opthea's stock price forecast for 2024? 4 equities research analysts have issued twelve-month price objectives for Opthea's shares. Their OPT share price …
WebApr 13, 2024 · Opthea has a market cap or net worth of $274.31 million. The enterprise value is $243.32 million. Important Dates Share Statistics Opthea has 58.36 million shares …
WebMar 31, 2024 · What is Opthea Ltd’s stock style? OPT’s stock style is Small Core. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining ... greenville north carolina headstonesWebApr 12, 2024 · Stocks United States Pharmaceuticals & Biotech Opthea NasdaqGS:OPT Stock Report Last Price US$5.00 Market Cap US$278.5m 7D 0.6% 1Y -33.7% Updated 30 Dec, 2024 Data Company Financials + 8 Analysts Opthea Limited NasdaqGS:OPT Stock Report Mkt Cap: US$278.5m Add to watchlist CompanyOverview 1Valuation 2Future … fnf static mod wikiWebOpthea Limited (CKDXF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. fnf statement meaningWebOpthea Limited (OPT.AX) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed S&P 500 Dow 30 Nasdaq Russell 2000 Crude Oil (+1.79%) Gold 1,969.80 (-0.53%) … greenville north carolina crossWebMELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to … View the basic OPT option chain and compare options of Opthea Limited on … Discover historical prices for OPT stock on Yahoo Finance. View daily, weekly or … Find the latest Opthea Limited (OPT) stock discussion in Yahoo Finance's forum. … Opthea Limited 650 Chapel Street Suite 0403 Level 4 South Yarra, VIC 3141 … Get the detailed quarterly/annual income statement for Opthea Limited (OPT). Find … See Opthea Limited (OPT) stock analyst estimates, including earnings and … Holder Shares Date Reported % Out Value; Victory Portfolios-Victory RS Small Cap … Find out all the key statistics for Opthea Limited (OPT), including valuation … Opthea First Half 2024 Earnings: US$0.17 loss per share (vs US$0.11 loss in 1H … Find the latest Opthea Limited (OPT) stock quote, history, news and other vital … fnf static memories mod game bananaWebMar 22, 2024 · Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing novel therapies to treat highly prevalent and progressive retinal eye diseases including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The Company’s lead product candidate … fnf static nightmareWebMar 30, 2024 · MELBOURNE, Australia, March 30, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, has... greenville north carolina florist